Allspring Global Investments Holdings, LLC Dyne Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$13.06 - $29.18 $14,470 - $32,331	-1,108 Reduced 47.8%	1,210 $34,000
Q4 2023 Jan 25, 2024	SELL	$6.62 - $13.64 $46,287 - $95,370	-6,992 Reduced 75.1%	2,318 $30,000
Q3 2023 Oct 27, 2023	BUY	$8.6 - $12.18 $80,066 - $113,395	9,310 New	9,310 $83,000
Q2 2023 Jul 18, 2023	BUY	$8.53 - $14.28 $3,079 - $5,155	361 Added 8.21%	4,758 $53,000
Q1 2023 Apr 13, 2023	BUY	$10.88 - $15.0 $47,839 - $65,955	4,397 New	4,397 $50,000

Others Institutions Holding DYN

# of Institutions

201

Shares Held

106M

Call Options Held

82.7K

Put Options Held

24.8K

Atlas Venture Life Science Advisors, LLC

8.02M
Shares

$261 Million
37.7% of portfolio
Fcpm Iii Services B.V. Naarden, P7

7.85M
Shares

$256 Million
40.83% of portfolio
Black Rock Inc. New York, NY

7.39M
Shares

$241 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

6.39M
Shares

$208 Million
3.76% of portfolio
Ra Capital Management, L.P. Boston, MA

6.05M
Shares

$197 Million
3.22% of portfolio

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.69B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account